Combining an adaptive transfer of NK cell approach to the melanoma metastases model, we found that CR3-deficient NK cells mediated better anti-tumor responses than CR3-sufficient NK cells, defining the role of CR3 in suppression of NK-dependent anti-tumor immunity. This evidence concerns the gene CRIPTO3 and melanoma.